FDA clears emergency use of lab-made antibodies to treat COVID-19

The FDA just cleared a medical advance that could play an important (if limited) role in treating COVID-19 patients. The administration has granted emergency use authorization for Regeneron’s lab-made monoclonal antibodies (a combo of casirivimab and...

source https://www.engadget.com/fda-clears-use-of-regeneron-monoclonal-antibodies-175202007.html